Skip to content
Full Committee Hearing

Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak

Date:
Time: 09:45am
Location: 106 Dirksen Senate Office Building

Panel I

  • Dr. Beth Bell

    Director, National Center for Emerging and Zoonotic Infectious Diseases
    Centers for Disease Control and Prevention
    Atlanta, GA
  • Dr. Peggy Hamburg

    Commissioner
    Food and Drug Administration
    Washington, DC
  • Dr. Lauren Smith

    Interim Commissioner
    Department of Public Health
    Boston, MA

Panel II

  • Barry Cadden

    Owner and Director of Pharmacy
    New England Compounding Center
    Framingham, MA

Panel III

  • Dr. Marion Kainer

    Director
    Healthcare Associated Infections & Antimicrobial Resistance Program, Tennessee Department of Health
    Nashville, TN
  • David G. Miller

    Executive Vice President and CEO
    International Academy of Compounding Pharmacy
    Missouri City, TX
  • Dr. Kasey K. Thompson

    Vice President, Office of Policy, Planning and Communications
    American Society of Health-System Pharmacists
    Bethesda, MD

Related Issues

Related Photos